Annexon Reports Q4 2025 Financial Results and Progress
30 Mar 2026 //
GLOBENEWSWIRE
Annexon Grants Inducement To New Employee Per Nasdaq LR
16 Mar 2026 //
GLOBENEWSWIRE
Annexon Issues Inducement Grants To New Hires Per Nasdaq LR
16 Jan 2026 //
GLOBENEWSWIRE
Annexon Grant Inducement To New Employee Per Nasdaq LR 5635(c)(4)
16 Dec 2025 //
GLOBENEWSWIRE
Annexon Completes Public Offering, Raises $86.25M
14 Nov 2025 //
GLOBENEWSWIRE
Annexon Unveils Q3 2025 Financials Update, Portfolio Advancements
10 Nov 2025 //
GLOBENEWSWIRE
Annexon Biosciences to Present at September Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Annexon Reports Q2 2025 Financials, Portfolio Progress
14 Aug 2025 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants Under Nasdaq 5635(c)(4)
16 May 2025 //
GLOBENEWSWIRE
Annexon Reports Q1 2025 Financial Results and Milestones
12 May 2025 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to New Employee Under Nasdaq
16 Apr 2025 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to New Employee Under Nasdaq Rule
17 Mar 2025 //
GLOBENEWSWIRE
Annexon Biosciences to Present at TD Cowen Health Care Conference
26 Feb 2025 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
18 Feb 2025 //
GLOBENEWSWIRE
Annexon Provides 2025 Outlook, Highlighting Momentum For Growth
13 Jan 2025 //
GLOBENEWSWIRE
Annexon Adds William “BJ” Jones To Board Of Directors
10 Jan 2025 //
GLOBENEWSWIRE
Annexon Biosciences to Present at 43rd J.P. Morgan Conference
07 Jan 2025 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants for New Employees
16 Dec 2024 //
GLOBENEWSWIRE
Annexon Inducement Grants to Employees Under Nasdaq LR 5635(c)(4)
15 Nov 2024 //
GLOBENEWSWIRE
Annexon Reports Q3 2024 Results & Key Milestones
14 Nov 2024 //
GLOBENEWSWIRE
Annexon Biosciences to Present at Jefferies London Conference
13 Nov 2024 //
GLOBENEWSWIRE
Annexon Presents Ph 2 Vision Preservation Data With ANX007 In Dry AMD
21 Oct 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)
16 Oct 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants To New Employees
16 Sep 2024 //
GLOBENEWSWIRE
Annexon Expands Leadership in Commercial, Medical Economics
03 Sep 2024 //
GLOBENEWSWIRE
Annexon Biosciences to Participate in Upcoming September Investor Conferences
29 Aug 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)
16 Aug 2024 //
GLOBENEWSWIRE
Annexon Reports Q2 2024 Results And Key Anticipated Milestones
12 Aug 2024 //
GLOBENEWSWIRE
Annexon Updates On ARCHER II Program In Geographic Atrophy
05 Aug 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant Under Nasdaq Rule 5635(c)(4)
16 Jul 2024 //
GLOBENEWSWIRE
Annexon To Present Phase 2 Data On ANX007 In Geographic Atrophy
11 Jul 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants To New Employees Under Nasdaq
17 Jun 2024 //
GLOBENEWSWIRE
Annexon Announces Pricing of $125 Million Underwritten Public Offering
05 Jun 2024 //
GLOBENEWSWIRE
Annexon`s neurological disease drug succeeds in late-stage study
05 Jun 2024 //
REUTERS
Annexon Announces Proposed Public Offering of Common Stock
04 Jun 2024 //
GLOBENEWSWIRE
Annexon To Host GBS Phase 3 Data Conference Call, Webcast
03 Jun 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants To New Employees
16 May 2024 //
GLOBENEWSWIRE
Annexon Reports Q1 2024 Results, Key Anticipated Milestones
13 May 2024 //
GLOBENEWSWIRE
Annexon Biosciences to Present at the Bank of America Health Care Conference
09 May 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants to New Employees Under Nasdaq Rule
16 Apr 2024 //
GLOBENEWSWIRE
Annexon to Present at the 23rd Annual Needham Virtual Healthcare Conference
03 Apr 2024 //
GLOBENEWSWIRE
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results
26 Mar 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to New Employee Under Nasdaq
18 Mar 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to New Employee Under Nasdaq Rule 5635(c)(4)
18 Mar 2024 //
GLOBENEWSWIRE
J.P. Morgan Predicts up to 140% Rally for These 2 ‘Strong Buy’ Stocks
13 Mar 2024 //
YAHOO FINANCE
Annexon to Host Virtual R&D Day on Guillain-Barr Syndrome
21 Feb 2024 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to New Employee Under Nasdaq Rule 5635(c)(4)
20 Feb 2024 //
GLOBENEWSWIRE
Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones
07 Jan 2024 //
GLOBENEWSWIRE
Annexon Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
27 Dec 2023 //
GLOBENEWSWIRE
Annexon Reports Phase 1 Results for ANX1502
20 Dec 2023 //
GLOBENEWSWIRE
Annexon Announces Pricing of $125.0M Underwritten Public Offering of Stock
20 Dec 2023 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants to New Employees Under Nasdaq Rule 5635(c)(4)
18 Dec 2023 //
GLOBENEWSWIRE
Annexon to Participate in the 6th Annual Evercore ISI HealthCONx Conference
22 Nov 2023 //
GLOBENEWSWIRE
Annexon Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Annexon Biosciences to Participate in Jefferies London Healthcare Conference
09 Nov 2023 //
GLOBENEWSWIRE
Annexon Reports Inducement Grants to New Employees Under Nasdaq Rule 5635(c)(4)
18 Oct 2023 //
GLOBENEWSWIRE
Annexon Biosciences to Participate in 2023 Cantor Global Healthcare Conference
19 Sep 2023 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to Employee Under Nasdaq Rule 5635(c)(4)
18 Sep 2023 //
GLOBENEWSWIRE
Annexon Highlights Reports Second Quarter 2023 Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
Annexon Reports Inducement Grant to New Employee Under Nasdaq Rule 5635(c)(4)
02 Aug 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support